Brief: Sequana Medical Announces Grant Of Additional DSR Patent In US

Sequana Medical NV

01/02/2023 06:05

Feb 1 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES GRANT OF ADDITIONAL DSR® PATENT
IN
UNITED STATES
    * US PATENT NUMBER 11,559,618 B2 HAS BEEN GRANTED ON 24
JANUARY
2023 AND COVERS, AMONG OTHER, EXPANSION OF COMPOSITION OF MATTER
AND METHOD FOR SEQUANA MEDICAL'S DSR THERAPY, INCLUDING
ADDITIONAL ONCOTIC AND OSMOTIC AGENTS
    * IN TOTAL, SEQUANA MEDICAL NOW HAS 14 PATENTS FILED OF
WHICH 5
GRANTED FOR ITS DSR PROGRAM, COVERING A BROAD RANGE OF ASPECTS,
BOTH FOR METHOD OF OPERATION AND COMPOSITION OF MATTER

Source text for Eikon:  ID:nGNEHC5LP 
Further company coverage:  SEQUA.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))